West-ward Recalls Lisinopril Tablets Due to Foreign Substance Presence
West-ward Pharmaceutical Corp. is recalling specific lots of Lisinopril Tablets, USP 40 mg, because uncharacteristic black spots were found in the tablets.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classified this as an FDA Class II recall. Per the rubric, an FDA Class II recall involving a foreign substance (stainless steel inclusions) in a drug product is categorized as Severe.
Plain-English summary
West-ward Pharmaceutical Corp. is recalling 32,550 bottles of Lisinopril Tablets, USP 40 mg. The affected products are packaged in 100-count and 1000-count bottles and are available by prescription only. The recall covers specific lots manufactured by West-ward Pharmaceutical Corp. and manufactured for Blu Pharmaceuticals.
The recall was initiated due to the presence of a foreign substance. Uncharacteristic black spots were identified in the tablets as a food-grade lubricant containing trace amounts of foreign particulates and stainless steel inclusions.
The affected products were distributed nationwide and in Puerto Rico. Patients and healthcare providers should discontinue use of the recalled lots and contact their healthcare provider for appropriate medical advice or alternative treatment.
The recalled product
- Product
- Lisinopril Tablets, USP 40 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1270-01); b) 1000-count tablets per bottle (NDC 0143-1270-10); Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724; and c) 1000-count tablets per bottle (NDC 24658-245-
- Manufacturer
- West-ward Pharmaceutical Corp.
- Category
- Drug — Prescription Medication
- Affected units
- 32,550
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (19)
- Lot #: a) and b) 69545A
- 69546A
- 69546B
- Exp 10/15
- 69547A
- Exp 11/15
- 69995A
- 69999A
- 69999B
- 70000A
- 70001A
- 70002A
- 70002B
- 70003A
- 70004A
- Exp 02/16
- c) 69548A
- 69549A
- 69877A
Distribution
Part of a larger recall action
This product is one of 2 recalled by West-ward Pharmaceutical Corp. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · West-ward Pharmaceutical Corp.
See all →- ModerateWest-Ward Recalls Fentanyl Citrate Injection Due to Impurity Failures
FDA (Drugs) · 2015-06-24
- ModerateWest-Ward Recalls Ethambutol Hydrochloride Tablets Due to Stability Failure
FDA (Drugs) · 2014-11-05
- ModerateWest-Ward Recalls Isoniazid Tablets Due to Dissolution Failure
FDA (Drugs) · 2014-07-09
- SevereWest-Ward Recalls Carisoprodol Tablets Due to Foreign Substance Presence
FDA (Drugs) · 2013-12-25
- SevereIrinotecan Hydrochloride Injection Recalled for Incorrect Formulation Calculation
FDA (Drugs) · 2013-11-13
Same hazard · foreign substance
See all →- ModerateHeritage Pharmaceuticals Recalls Clindamycin Palmitate Hydrochloride Due to Foreign Particles
FDA (Drugs) · 2026-08-19
- HighPrednisolone Acetate Ophthalmic Suspension Recalled for Foreign Substance
FDA (Drugs) · 2026-07-08
- ModerateCorlanor Ivabradine Tablets Recalled for Foreign Substance Contamination
FDA (Drugs) · 2026-07-01
- LowHydroxyzine Hydrochloride Oral Solution recalled for foreign substance
FDA (Drugs) · 2026-07-01
- ModerateCorlanor ivabradine tablets recalled for presence of foreign substance
FDA (Drugs) · 2026-07-01